Press-center

Zebra Medical Vision, the AI medical imaging insights company, announced Wednesday it has received its fourth FDA 510(k) clearance for the HealthCXR device intended for the identification and triaging of pleural effusion in chest X-rays.

TORONTO – A team of Toronto doctors has completed the world’s first brain aneurysm surgery using robotics, leading to hope of better treatment for aneurysm and stroke patients, especially in areas where specialized surgical expertise isn’t available.

American contact lens retailer 1-800 Contacts announced this week that it entered into a definitive written agreement to acquire Israeli startup 6over6 Vision, which developed a smartphone-based healthcare platform that offers mobile vision tests.

Israeli startups Healthymize, a medical tech company that turns smart devices into patient monitoring devices for voice-affecting diseases, and Beyond Verbal, which developed voice-enabled AI to create vocal biomarkers for personalized health screening and emotion monitoring, have merged to form a company called Vocalis Health and announced the closure of a $9 million funding round this week. Venture capital fund aMoon, co-founded by Dr. Marius Nacht, led the round.

Israeli scientists say a new study has shown that a small molecule called PJ34 triggered the self-destruction of human pancreatic cancer cells in mice.

Israeli pharmaceutical company Raziel Therapeutics announced this week a $22 million Series C preferred stock financing led by Israeli VC firm Pontifax, with the participation of existing investors Dr. Shmuel Cabilly and Docor International. New investors included Catalyst Fund, Quark Venture and Peregrine Ventures.

Israeli biomedical tech company Theranica, which develops advanced wearable devices that address prevalent medical conditions and diseases, was named as one of 36 game-changing companies in 2020 by New York-based research firm CB Insights. It was the only Israeli company on the list.

Israeli AI medical imaging startup DiA Imaging Analysis will partner with IBM Watson Health, a provider of innovative, AI, enterprise imaging and interoperability solutions used by medical professionals worldwide, the company announced this week.

JRDF, a nonprofit global organization funding Type 1 diabetes research, has partnered with the Israel Science Foundation (ISF), the funding organization that provides governmental and public support for basic research in Israel, to launch a new initiative to invest in local research driving cures for Type 1 diabetes (T1D) in Israel.

VR system developed by former Israeli fighter pilots helps neurosurgeons rehearse difficult procedures and show the patient what will happen.

New technique from Israel uses cannabidiol to open a channel for drugs to target cancer cells only, potentially enabling a gentler course of chemo.

Corindus Vascular Robotics reported that it has completed its first machine-assisted brain surgery procedure in humans.

Scientists have made artificial nerve cells, paving the way for new ways to repair the human body. The tiny "brain chips" behave like the real thing and could one day be used to treat diseases such as Alzheimer's.

'Instead of having to check millions of molecules, we may check just 20, 100 or maybe up to 3,000 molecules,' says Jerusalem-based Pepticom.

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leading supplier of intelligent laboratory automation solutions, today announced the optimization of the Cyto-Mine® Single Cell Analysis System through integration with PAA’s automated plate handler, S-LAB™. The addition of S-LAB to the Cyto-Mine provides researchers with a further streamlined solution for single cell analysis in biopharmaceutical workflows.

Food allergies are rising dramatically around the world. One startup thinks it may have the solution – a device that acts like a mini nose sniffing food for dangerous allergens.

“The mostly night-time atrial fibrillation was shown to be caused by a mutation in a gene (KCND2), encoding a crucial component of a potassium ion channel (Kv4.2) in the heart."

"We are encouraged by the emerging safety profile and initial signals of anti-tumor activity of COM701," said Compugen president and CEO Dr. Anat Cohen-Dayan.

Ahead of International Diabetes Day, November 14, Israeli startup Betalin Therapeutics announced that it is beginning the application process for clinical trials of its revolutionary artificial pancreas.

Your body is composed of about 10 trillion human cells. It’s also home to about 100 trillion tiny microbes, mainly bacteria that wield astonishing power over your health.

Tooth enamel can now be made to repair itself by applying a special gel. The product could save people from developing cavities that require dental fillings.

An experimental vaccine for dengue fever is 80 per cent effective at preventing infections, according to preliminary results from a large clinical trial.

Getting a clear view of your GI tract typically involves the uncomfortable process of having a long endoscope snaked down the esophagus. Thankfully, capsule endoscopy technology is replacing many procedures that have required an endoscope. These swallow-able devices are able to withstand the harsh, acidic environment of the gut, and can provide high-resolution images, as well as temperature, pH, and pressure data.

Just as every handwritten signature is unique, so is every cancerous tumor. Researchers at the Technion-Israel Institute of Technology have now used artificial intelligence and big datato decode the unique signatures of certain cancer cells.

Chemical analysis of blood samples, combined with an artificial intelligence program, could speed up the diagnosis of brain tumors, according to research presented at the 2019 NCRI Cancer Conference.

In the earliest days of medicine, people needed a trip to the doctor like a hole in the head. Because that’s exactly what they got: Healers and witch doctors were downright wanton in their use of trepanning — the practice of sharpening a stone to cut away a section of skull in fully conscious patients. Trepanning was done to relieve headaches, remove fractured skull fragments, provide spirits with an easy entrance or escape, sometimes just to provide rondelles — the leftover bony disks valued as charms or talismans.

Yogi Berra was right when he said, “The future ain’t what it used to be.” Only he wasn’t right in the way he meant it, which was usually the case. The future really isn’t what it used to be — it’s much, much brighter.

Hospital bedsheets and patient gowns are a major conduit for transferring dangerous bacteria estimated to infect 1.7 million hospitalized Americans and 3.5 million hospitalized Europeans every year. In the United States, hospital-acquired infections kill about 98,000 people yearly.

Ewing’s sarcoma is a very rare type of cancerous tumor that got its name from Dr. James Ewing, the physician who first described it almost exactly a century ago. It affects children through young adults – mostly teens – and can appear anywhere in the body, but it usually originates in the long bones of the arms and legs, the pelvis or the chest.

A new study led by Israeli researchers has found evidence that there could be damage to the brain’s protective barrier even without a reported concussion.

Sheba Medical Center, Tel HaShomer, in collaboration with Telesofia Medical, has announced the launch of a new, personalized telemedicine program that will enable cancer patients to quickly reach their doctors and get personalized feedback via video within the comfort of their own homes.

Sight Diagnostics’ new device gives results of a standard blood count test in just 10 minutes, without lab processing.

Predictix by Taliaz aims to help psychiatrists match each patient with the most effective prescription.

Belong life for cancer patients and caregivers uses artificial intelligence to cut through data clutter. Users only see the most relevant information.

Israeli and international scientists pinpoint protein that regulates exhaustion in T cells in discovery that may help fight disease.

TEL AVIV - Israel’s Pluristem Therapeutics Inc reported on Wednesday positive results from a series of studies in animals of its placenta-based stem cell therapy to treat acute radiation syndrome (ARS).

Magenta Medical, an Israeli developer of a miniaturized blood pump to help treat heart failure, has raised funds from investors led by venture capital firm New Enterprise Associates (NEA), a US-based VC firm.

The future of cancer treatments rests also on the shoulders of Natural Killer cells, according to a recent study conducted by Israeli Professor Angel Porgador, of the Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, and the National Institute of Biotechnology in the Negev (NIBN).

Math model developed by Hebrew University team could pave the way for physicians to see beginnings of Alzheimer’s or Parkinson’s.

Weizmann Institute team says early interactions between immune cells and bacteria determine the outcome of illnesses.

Tel Aviv University (TAU) researchers say they have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer.

Israel’s Nurami Medical is testing its nanofiber bandage that mimics the brain’s protective membrane and guards against infection and leakage.

The researchers turned their attention to diagnosing the onset of tuberculosis, caused by bacteria that can hide dormant in the body for years.

Innovative AI system manages to identify all important clinical cases of medium or severe obstructive sleep apnea.

Medasense for pain management and Vectorious for heart-failure monitoring were among 50 companies selected from a field of 800 applicants.

The Israel Innovation Authority and the Israeli Ministry of Economy and Industry on Wednesday announced grants of over NIS 25 million as part of an R&D program to support new and innovative medical technologies.

Israeli scientists say their biocompatible nontoxic medical glue, delivered with a glue gun, is better than staples and stitches inside the body.

Third annual GlobalSTL Health Innovation Summit in St. Louis chooses 16 innovative companies, mostly Israeli, to present to healthcare execs and VCs.

Scientists at Tel Aviv University, working together with colleagues at Cambridge University in the UK and the Max Planck Institute in Gottingen and Ludwig-Maximilians-Universität München in Germany, say they have identified a novel method for detecting the early aggregation of a protein that signals the onset of Parkinson’s disease in mouse models.

In the US, food allergies trigger anaphylactic shock in someone every six minutes. Israel's SensoGenic may have a way to cut those stats drastically.

New research has revealed that men who eat two or more servings of yogurt per week may reduce their risk of developing pre-cancerous growths that can lead to bowel cancer. If the results can be replicated, yogurt may be a “widely acceptable modifiable factor” for bowel cancer, say the researchers.

For the first time, researchers have mapped the different types of cells in the lungs and identified key differences between healthy airways and airways affected by asthma in a study published in Nature Medicine. The findings could help advance the discovery of new drug targets for the condition.

Israel’s embrace of new technologies like AI in the medical field helps make the magic happen, says Philips Chief Innovation and Strategy Officer Jeroen Tas.

A new therapy to re-engage the heart's natural electrical pathways—instead of bypassing them—could mean more treatment options for heart failure patients who also suffer from electrical disturbances, such as arrhythmias, according to research led by the University of Chicago Medicine.

Top 10 companies in medical 3D printing Unquestionably, one of the most exciting areas of the 3D printing space is that of bioprinting. Using layer-by-layer fabrication procedures, several companies are in the process of pushing forward a new shift within the medical transplantation, implant, and surgical spaces by exploiting 3D bioprinting.

Telerad Tech launches AI-powered product to detect early-stage breast cancer. Telerad Tech has launched the AI-powered product Mammo Assist to help the radiologists make an early-stage detection of breast cancer disease.

A drug commonly used to treat multiple sclerosis may, after necessary modifications, one day be used to treat patients with epilepsy, researchers in Prof. Inna Slutsky's lab at the Sackler Faculty of Medicine and Sagol School of Neuroscience at Tel Aviv University have discovered.

A product review It’s a long way and even bored to think about diagnostics. Standing in queues, providing blood samples, waiting for hours outside the laboratory and finally identifying the exact cause of illness, is an annoying task. This can be put up with for common health problems. But for emergencies, such as sudden heart stroke where time and accuracy of diagnostics plays a key role, this process will no more sustain. So, Samsung in association with its global collaboration partner, Thermo Fisher Scientific, introduced a digital health diagnostics tool known as Samsung LABGEO IB 10. It has many unique features which made it be named as the portable diagnostics. What do you think about?

During the last years, there have been a lot of advancements in the area of diagnostics. At first, this process is very long and even boring. After the entrance of digitalization into the field of medicine, there is a reduction of time, and even many traits can be unmasked from it. But the problem is that there are certain areas (rural) which are not digitalized to adopt these diagnostics. There is also an issue of cost perspective. To fulfil these rural circumstances, paper diagnostics comes into the picture.

The future is here. In a world first, Israeli scientists have created a live heart in a revolutionary new 3D printing process that combines human tissue taken from a patient. In November, Tel Aviv University researchers said they invented the first fully personalized tissue implant engineered from a patient’s own biomaterials and cells, paving the way for new technology that would make it possible to develop any kind of tissue implant from one small fatty tissue biopsy.